(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, making it the first treatment available for patients who experience ...

Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...

A recent study has identified PhSLB1 as a crucial regulator of branch development in petunia (Petunia hybrida), offering ...

Opioid use disorder is associated with more than 350,000 deaths annually worldwide. Guided by the need for an increased understanding of critical neurobiological features of addiction, researchers ...

Opioid use disorder is associated with more than 350,000 deaths annually worldwide. Guided by the need for an increased ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

By analyzing huge amounts of biological data, the use of machine learning accelerates the identification of critical control ...

A new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...

Discover practical lifestyle changes to reduce your Alzheimer's risk and protect your brain health through diet, exercise, ...

The goal of genome editing technology is to develop strategies for the correction of those mutations that are responsible of ...

Technological advancements over the past few decades have unraveled the diversity and adaptability of tumors, shedding light ...

Resilience relies on the brain’s ability to regulate emotion, adapt, and recover. Myelin plasticity helps speed up and stabilize resilient brain responses. Genes like FKBP5 and BDNF affect how people ...